Association Between Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Outcomes Based on Race and Sex Among Patients With and Without Diabetes Mellitus: A Meta-Analysis of Nine Randomized Controlled Trials
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been shown to reduce major adverse cardiovascular events (MACEs) in patients with type 2 diabetes mellitus (T2DM) and high cardiovascular risk. However, the efficacy of GLP-1 RAs on the outcomes of MACEs across...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
IMR Press
2026-01-01
|
| 叢編: | Reviews in Cardiovascular Medicine |
| 主題: | |
| 在線閱讀: | https://www.imrpress.com/journal/RCM/27/1/10.31083/RCM45797 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
